Sunday, August 11, 2019

USFDA issues 6 observations to Natco Pharma's API facility near Hyderabad

Natco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.

from Moneycontrol https://ift.tt/2N28gzw
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Trading Books